REG - HeiQ PLC - Restructuring and Delisting

HeiqAnnouncement

22/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241022:nRSV0281Ja&default-theme=true

RNS Number : 0281J  HeiQ PLC  22 October 2024

This announcement contains inside information

 

HeiQ Plc

(the "Company")

Restructuring and Delisting

As detailed in the Company's trading update on 12 September 2024, with the
exception of the Life Sciences business unit, the Company continues to face
significant challenges in its core business units in Textiles, Flooring, and
Antimicrobials due to ongoing curtailed demand. The industry wide consensus is
that market conditions are only expected to recover towards the second half of
2025 and accordingly, the Company does not expect to see a significant
improvement in performance of these core business units before then. In
response, the Company has initiated a second restructuring plan aimed at
reducing its costs by up to an additional 20% by the end of 2025. Key elements
of this restructuring include:

·    Reducing central organisation costs

·    Relocating and streamlining of capabilities to hubs in Portugal, USA
and Thailand

·    Scaling back non-core elements of  the Company's innovation pipeline
and a reduction of associated corporate marketing activities

The Company has reviewed its strategic product portfolio within its core
business units and is considering selective divestments, providing a
commercially attractive offer or offers can be achieved. Any proceeds from
divestments, should they materialize, would be used to finance HeiQ's three
ventures (HeiQ AeoniQ, HeiQ GrapheneX and HeiQ Xpectra) and to accelerate the
growth of its Life Sciences business unit.

Fundraising to scale-up Venture Units

·    The Company is seeking substantial financing for its HeiQ AeoniQ
venture, which, as reported in its recent trading update, recently met a key
value-creating milestone by launching to market the world's first AeoniQ
plastic-minimized sneaker with Hugo Boss. As previously announced, the Company
embarked on a process to raise equity financing exclusively for the  HeiQ
AeoniQ subsidiary level.

·    The Directors believe that the Company is close to meeting key
milestones for its other two ventures, HeiQ GrapheneX and HeiQ Xpectra, and
plans to accelerate their go-to-market strategies with additional external
financing.

The Directors consider that the historically low valuation of HeiQ Plc limits
the Company's ability to secure financing at HeiQ Plc level and complicates
its efforts to raise funds for the various venture platforms at a subsidiary
level.

Delisting

The Directors have concluded that the administrative, regulatory and cost
burden associated with maintaining the Company's listing is, in their opinion,
disproportionate to the benefits.   In order to implement the restructuring
programme detailed above, as well as to assist in the Company's financing
efforts for its ventures, the Board has therefore concluded that it is
necessary to cancel the listing of the Company's ordinary shares (the
"Shares") on the Official List (equity shares (transition) category) of the
Financial Conduct Authority ("FCA") and to cancel the admission to trading of
the Shares on the Main Market for listed securities of the London Stock
Exchange ("LSE") (the "Delisting"). The Directors believe that the Delisting
would facilitate its restructuring programme, through a major reduction in
annualized costs  associated with being a listed company. Furthermore, the
Directors believe that the Delisting would greatly assist the Company to raise
financing in the private markets for its venture platforms at higher
valuations and enable their growth and value creation for Company's
shareholders.

As a company listed on the equity shares (transition) category, the Company is
not required to obtain the approval of shareholders for the Delisting but is
required under UK Listing Rule 21.2.17 to give at least 20 business days'
notice of the intended cancellation.

Accordingly, HeiQ has requested that (i) the FCA cancel the listing of the
Shares on the Official List of the FCA, and that (ii) the LSE cancels the
admission to trading of the Shares on the Main Market for listed securities of
the LSE.  It is anticipated that the Delisting will become effective from
08:00 a.m. (London time) on 19 November 2024. Investors holding Shares
following the Delisting will remain a shareholder of HeiQ plc and continue to
be entitled to exercise all of the rights attaching to the Shares and their
attention is drawn to the paragraph below entitled "Dealing Arrangements",

The Company intends to publish its Annual Accounts for the 18-month period
ending 30 June 2024 by 31 October 2024, as required by the UK Listing Rules.
The Company's 2024 Annual General Meeting is expected to take place in
November 2024, further details of which will be announced in due course.

Dealing Arrangements

Following the Delisting, the Shares will be admitted to trading on the JP
Jenkins securities matching platform with effect from 20 November 2024.

JP Jenkins provides a securities matching venue for unlisted or unquoted
assets in companies, enabling shareholders and prospective investors to buy
and sell shares on a matched bargain basis. JP Jenkins is a trading name of
InfinitX Limited and Appointed Representative of Prosper Capital LLP
(FRN453007).

Shareholders wishing to trade Shares on the JP Jenkins platform can place
orders through their stockbroker. Trades will be conducted at a level that JP
Jenkins is able to match a willing seller and a willing buyer. Trades can be
conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK
regulated stockbroker.

The indicative pricing for the ordinary Shares (ISIN: GB00BN2CJ299), as well
as the transaction history, will be available on the JP Jenkins website at
(https://jpjenkins.com/company/HeiQ/).

The provision of the matched bargain facility will be kept under review by the
Board and, in determining whether to continue to offer a matched bargain
facility, the Company shall consider expected (and communicated) shareholder
demand for such a facility, the composition of the Company's register of
members and the associated costs to the Company and its shareholders.

For further information, please contact: investors@heiq.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDDFLFLZBLZFBV